> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Hold on Dyne Muscular Dystrophy IND
- URL: https://www.fdaweb.com/fda-hold-on-dyne-muscular-dystrophy-ind/
- Published: 2022-01-20T12:00:00.000Z
- Updated: 2026-09-14T17:29:17.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5150967

FDA has placed a clinical hold on Dyne Therapeutics’ IND for a clinical trial of its DYNE-251 in patients with Duchenne muscular dystrophy amenable to skipping exon 51\. The agency requested additional clinical and non-clinical information for Dyne-251, the company [says](https://investors.dyne-tx.com/news-releases/news-release-details/dyne-therapeutics-announces-fda-clinical-hold-ind-application?ref=fdaweb.com). Dyne says it expects to submit its response to FDA with data from existing and ongoing studies in the second quarter.